Global Scleritis Market Overview: Trends Shaping Growth to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Scleritis Industry In 2025?

The scleritis market has demonstrated significant expansion in recent years. Its value is anticipated to rise from $3.6 billion in 2024 to $3.93 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.0%. The past growth in this market can be linked to factors such as an increasing prevalence of autoimmune disorders, enhanced awareness of ocular health, an expanding geriatric demographic, better access to ophthalmic care, and the global development of healthcare infrastructure.

The scleritis market size is anticipated to undergo significant expansion in the upcoming years. It is projected to reach $5.49 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.7%. The expected growth during this forecast period can be attributed to an increase in eye-related health conditions, heightened awareness regarding ocular well-being, increased healthcare spending, expanding research in ophthalmology, a rising demand for personalized medicine, and an increase in available treatment options. Prominent trends anticipated in the forecast period include the creation of targeted biologic therapies, improved formulations of immunosuppressive drugs, advancements in imaging technologies, the adoption of minimally invasive diagnostic tools, the implementation of personalized medicine approaches, progress in drug delivery systems, and AI-driven solutions for diagnosis and treatment planning.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21283&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Scleritis Industry?

The increasing prevalence of autoimmune diseases is anticipated to propel the growth of the scleritis market. These conditions occur when the body’s immune system mistakenly attacks its healthy cells and tissues, perceiving them as foreign invaders. The surge in autoimmune diseases is associated with genetic predispositions, environmental factors, lifestyle changes, and increased awareness leading to more accurate diagnoses. Autoimmune diseases contribute to scleritis by triggering an inflammatory immune response that erroneously targets the scleral tissue, resulting in pain and redness. For instance, in November 2024, according to Versorgungsatlas.de, a Germany-based organization, in 2022, among 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, yielding a raw prevalence rate of 8.61%. Consequently, the rising prevalence of autoimmune diseases is a key factor driving the expansion of the scleritis market.

What Are The Major Segment Types Covered In The Scleritis Market?

The scleritismarket covered in this report is segmented –

1) By Type: Anterior Scleritis; Posterior Scleritis; Other Types

2) By Treatment: Medication; Surgery; Other Treatment

3) By Distribution Channel: Direct Tender; Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channel

4) By End-Users: Hospitals; Specialty Clinics; Home Healthcare; Other End-Users

Subsegments:

1) By Anterior Scleritis: Non-Necrotizing Anterior Scleritis; Necrotizing Anterior Scleritis

2) By Posterior Scleritis: Diffuse Posterior Scleritis; Nodular Posterior Scleritis; Scleritis With Choroidal Involvement

3) By Other Types: Chronic Scleritis; Recurrent Scleritis; Infectious Scleritis

How Are Trends Influencing The Scleritis Market?

Prominent companies operating within the scleritis market are concentrating on developing innovative products, such as eye drops, to target the underlying inflammation and provide practical, non-invasive therapeutic options for patients. Eye drops are fluid solutions designed for direct application to the eyes to manage conditions including irritation, dryness, inflammation, or infections. For instance, in May 2023, Entod Pharmaceuticals, an India-based pharmaceutical firm, introduced CYCLOTEARS eye drops in India and globally. This new therapy for inflammatory eye disease integrated proprietary SEDDS technology. The product enhances drug delivery and efficacy, offering a groundbreaking method to address inflammation in DED. This innovation represents a significant step forward in the treatment of eye inflammation, ocular myositis, and scleritis.

Which Major Industry Participants Are Leading The Scleritis Market Growth?

Major companies operating in the scleritis market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceuticals USA Inc., Baxter International Inc., Boehringer Ingelheim, Regeneron Pharmaceuticals Inc., Fresenius Kabi USA LLC, Sun Pharmaceutical Industries Ltd., Perrigo Company, Horizon Therapeutics plc, Aurobindo Pharma Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals, Alvogen, Accord Healthcare, West-Ward Pharmaceuticals, Jubilant Cadista Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Zydus Pharmaceuticals Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/scleritis-global-market-report

Which Geographies Are Emerging As Strong Markets For The Scleritis Industry?

North America was the largest region in the scleritis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the scleritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Scleritis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21283&type=smp

Browse Through More Reports Similar to the Global Scleritis Market 2025, By The Business Research Company

Arthritis Monoclonal Antibodie Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/arthritis-monoclonal-antibodie-global-market-report

Psoriatic Arthritis Treatments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report

Companion Animal Arthritis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795